Altimmune (ALT) PT Lowered to $14 at Jefferies Citing Discontinuation of CV-19 Vaccine
Tweet Send to a Friend
Jefferies analyst Kelechi Chikere lowered the price target on Altimmune (NASDAQ: ALT) to $14.00 (from $24.00) while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
